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Eukaryotic cells possess several mechanisms to protect the integrity of their DNA against damage. These include cell-
cycle checkpoints, DNA-repair pathways, and also a distinct DNA damage–tolerance system that allows recovery of
replication forks blocked at sites of DNA damage. In both humans and yeast, lesion bypass and restart of DNA
synthesis can occur through an error-prone pathway activated following mono-ubiquitination of proliferating cell
nuclear antigen (PCNA), a protein found at sites of replication, and recruitment of specialized translesion synthesis
polymerases. In yeast, there is evidence for a second, error-free, pathway that requires modification of PCNA with non-
proteolytic lysine 63-linked polyubiquitin (K63-polyUb) chains. Here we demonstrate that formation of K63-polyUb
chains protects human cells against translesion synthesis–induced mutations by promoting recovery of blocked
replication forks through an alternative error-free mechanism. Furthermore, we show that polyubiquitination of PCNA
occurs in UV-irradiated human cells. Our findings indicate that K63-polyubiquitination guards against environmental
carcinogenesis and contributes to genomic stability.
Citation: Chiu RK, Brun J, Ramaekers C, Theys J, Weng L, et al. (2006) Lysine 63-polyubiquitination guards against translesion synthesis–induced mutations. PLoS Genet 2(7):
e116. DOI: 10.1371/journal.pgen.0020116
Introduction
In contrast to DNA-repair pathways, DNA damage toler-
ance (DDT) is characterized by bypass of DNA lesions rather
than their direct removal or repair. The DDT pathway is
likely responsible for the ability of cells to continue to
proliferate with tremendous amounts of damage in their
genomes [1]. The genetic and mechanistic basis of DDT is best
understood in yeast, where it is known to be an extremely
important determinant of the toxicity and mutagenicity of
many DNA-damaging agents [2,3]. Often referred to as RAD6-
dependent repair or post-replication repair, DDT requires
interaction of the E2 ubiquitin (Ub) conjugase RAD6 and the
E3 Ub ligase RAD18 at sites of DNA damage [4]. Here they
mediate mono-ubiquitination of proliferating cell nuclear
antigen (PCNA) at K164 and subsequent recruitment of a
specialized translesion synthesis (TLS) polymerase capable of
replication past the lesion [5,6]. Several yeast and mammalian
TLS polymerases have been identified, including POLg
(RAD30A), POLi (RAD30b), REV1, REV3, and POLj [7].
These are highly error-prone polymerases that allow repli-
cation past a variety of DNA lesions [7]. POLg plays a
uniquely important role in the repair of UV damage as it
mediates error-free bypass of thymine–thymine dimers, the
most common UV-induced lesion [8]. Saccharomyces cerevisiae
RAD6 and RAD18 mutants that are unable to carry out DDT
are highly sensitive to various genotoxic agents including UV
irradiation and methyl methane sulfonate (MMS) [9]. These
mutants also show a reduction in UV-induced mutations [10]
that arises due to the inability to recruit the error-prone TLS
polymerases [11].
Genetic epistasis studies in yeast have established a second
arm of the DDT pathway that is distinct from TLS and is
referred to as damage avoidance [5,12–14]. This pathway is
also downstream of RAD6/RAD18, but in contrast to the
error-prone TLS pathway resolves blocked replication forks
through an error-free manner. Its mechanism is not fully
understood, but may involve fork reversal and recombination
with the undamaged replicated sister chromatid [5]. This
damage-avoidance pathway requires a second ubiquitination
complex composed of RAD5 and the UBC13/MMS2 hetero-
dimer [5]. UBC13/MMS2 is a unique Ub conjugase that
synthesizes polyUb chains linked through K63–G76 bonds
rather than through the typical K48–G76 bonds [13].
Although lysine 63-linked polyubiquitin (K63-polyUb) chains
can serve as competent proteolytic signals, they are less
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efficient at targeting substrates to the proteasome than K48-
linked chains [15], and the proteolytic activity of the
proteasome may not be required for error-free repair [13].
In yeast, a model has emerged in which error-free damage
avoidance occurs when mono-ubiquitinated PCNA becomes
further modified by K63-polyUb via RAD5 and MMS2/UBC13.
Interestingly, modification of K164 in PCNA by sumoylation
rather than by ubiquitination reduces homologous recombi-
nation [16,17].
There is convincing evidence that the DDT pathway, and
particularly the TLS arm, is also important in higher
eukaryotes including humans. Mouse and human homologs
of RAD6, RAD18, PCNA, and many of the TLS polymerases
have been identified [18]. The TLS polymerases form foci at
sites of DNA damage following UV irradiation and are
associated with other proteins in the replication machinery
[19]. As in yeast, RAD6 and RAD18 mediate mono-ubiquiti-
nation of PCNA at K164 in UV-irradiated mammalian cells in
a dose- and time-dependent manner [11]. Mono-ubiquitina-
tion of human PCNA has been suggested to provide a signal
for polymerase switching since it leads to its increased
association with POLg via its ubiquitin-binding domain
(UBD) or the UBZ (ubiquitin-binding zinc-finger) in this
TLS polymerase [20]. In vitro studies have also demonstrated
that mono-ubiquitination of PCNA in yeast can stimulate the
activities of both POLg and REV1 [21]. Recently, the
deubiquitinating (DUB) enzyme USP1 was shown to directly
remove the monoUb from PCNA, leading to the suggestion
that USP1 is required to suppress the error-prone activity of
TLS [22]. The functional importance of TLS is exemplified by
the fact that mutations in POLg are responsible for the
variant form of Xeroderma Pigmentosum (XP), a disease
characterized by a 2,000-fold increased risk of developing
skin cancer [8]. In contrast to other XP patients, those with
the variant form (XPV) of Xeroderma Pigmentosum have no
defect in excision repair [8], but are deficient in post-
replication repair [23]. Furthermore, they display enhanced
mutation at T–T sites, owing to usage of an alternative error-
prone TLS polymerase [24].
In contrast to TLS, the importance of the damage-
avoidance arm of DDT in mammalian cells is not yet firmly
established. Perhaps the strongest evidence supporting a role
for this pathway comes from Li et al., who showed that
antisense inhibition of hMMS2 resulted in an increase in
mutation frequency [25]. Nonetheless, several open questions
remain to be resolved. First, a human homolog of RAD5 has
not yet been identified. This may be due to the fact that yeast
RAD5 contains a helicase activity required for its function in
DNA double-strand break repair, but is unimportant for DDT
[26]. These authors speculated that RAD5 in higher organisms
may have evolved to lose this domain. Second, although
homologs of MMS2 exist (hMMS2 and hCroc1) and are able to
functionally complement loss of yeast MMS2 [27], they are
additionally required for polyubiquitination of proteins in
pathways unrelated to DDT [28]. Third, although evidence for
human PCNA mono-ubiquitination is strong [11,29], there is
less evidence for its polyubiquitination. High molecular
weight bands in PCNA Western blots were noted in mouse
fibroblasts following UV irradiation [11]. However, Kan-
nouche and colleagues found no evidence for polyubiquiti-
nation in human fibroblasts [29]. They concluded that polyUb
forms of PCNA were either insignificant, occurred only at low
levels, or were rapidly turned over [29]. Thus, whether
polyubiquitination of PCNA and subsequent activation of
an error-free damage-avoidance pathway is evolutionarily
conserved in humans is a source of uncertainty that we sought
to resolve.
Here, we provide evidence that the ability to create K63-
based polyUb chains is required for an error-free damage-
avoidance pathway in human cells. We implicate this
ubiquitination step in a pathway that contributes to genomic
stability by suppressing translesion polymerase–mediated
mutagenesis. Moreover, we show that DNA damage–induced
PCNA polyubiquitination is indeed conserved in human cells,
suggesting that this Ub-based molecular switch plays a
decision role in directing repair in either an error-free or
error-prone manner.
Results
Dominant Negative Approach to Disrupt K63-PolyUb
Chain Assembly
In order to directly investigate the functional importance
of K63-linked polyUb chains in DDT, we employed a strategy
similar to that first described in yeast, to specifically inhibit
assembly of these chains. In yeast, replacement of Ub with a
mutant in which lysine 63 is mutated to arginine (K63R)
disrupts the error-free arm of DDT and results in a
phenotype equivalent to loss of UBC13 or MMS2 [14]. The
K63R mutation disrupts K63-polyUb chain assembly, but has
no effect on K48-linked chains that mediate proteasomal-
based protein turnover [14]. In human cells, an equivalent
knock-in approach is not feasible because Ub is expressed
from multiple genes. The UBA52 and UBA80 genes encode a
Ub monomer fused in frame with ribosomal subunits, while
the UBB and UBC genes encode variable-length linear
polymers of (typically three to four Ub and nine Ub proteins,
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Synopsis
Genome instability is associated with increased cancer risk, and thus
considerable effort has been put into unraveling the mechanisms
underlying genome surveillance. Guarding the integrity of DNA are a
number of DNA-repair and cell cycle–control systems. Insight into
how these pathways become activated is crucially important to the
understanding of carcinogenesis and in the development of cancer
treatments. This study concerns a distinct pathway that promotes
the tolerance of DNA damage during its replication phase. Prior
attempts to investigate this pathway in human cells have been
difficult due to extensive redundancy in the genes that carry out this
process. Previous knowledge from lower organisms suggested the
requirement for enzymes capable of constructing a chain of
ubiquitin molecules linked in a specific manner. The authors used
a novel approach to disrupt the formation of these ubiquitin chains
in human cells and found that this caused a significant increase in
mutations after exposure to UV light. Several lines of evidence
implicate a family of error-prone enzymes, called translesion
synthesis polymerases, in the formation of these mutations.
Furthermore, they provide evidence suggesting that proliferating
cell nuclear antigen (PCNA), a protein found at sites of replication, is
the relevant target of these chains in human cells. These findings
indicate that polyubiquitination guards against environmental
carcinogenesis and contributes to genomic stability.
respectively) [30]. The fusion proteins are cleaved by DUB
enzymes to release individual Ub monomers.
Our approach was to express the K63R-Ub mutant in trans
so that it competed with wild-type (WT) Ub for inclusion into
polyUb chains. Its incorporation blocks further ubiquitina-
tion through K63 and thus acts in a dominant way. In a
previous study, we validated and used this approach to
specifically suppress K48-linked Ub chains by expressing a
K48R-Ub mutant [31]. This same construct has also been used
to inhibit K48 polyubiquitination in transgenic mice [32].
Here, we expressed a six-his-tagged K63R-Ub or WT-Ub fused
in frame with GFP from the UbC promoter (Figure 1).
Expression yields a fusion protein that is cleaved, releasing
a six-his-tagged Ub monomer and free GFP (Figure 1B). GFP
was used to sort pools of cells with stable high expression of
the transgene. Both WT-Ub and K63R-Ub monomers were
efficiently incorporated into polyUb chains as evidenced by
their detection in high molecular weight smears character-
istic of the heterogeneity of ubiquitinated proteins (Figure
1B). The K63R-Ub mutant did not affect normal cell
proliferation as demonstrated by the identical growth rates
in the sorted stable high K63R-Ub-GFP–expressing pools and
in the similarly sorted WT-Ub-GFP–expressing and the
untransfected cells (Figure 1C). Furthermore, disrupting
K63-polyUb chain formation did not alter normal protea-
some-mediated protein degradation of p53 or HIF1a (un-
published data). These data indicate that the K63R-Ub fusion
protein is properly processed into K63R-Ub monomers,
incorporates normally into chains, and does not alter the
ability of the proteasome to recognize polyubiquitinated
substrates targeted for degradation.
Disruption of K63-PolyUb Chain Assembly Sensitizes Cells
to Cisplatin—but Not UV—Induced Cell Death
Creation of stable cell lines expressing WT-Ub or K63R-Ub
allowed us to examine the role of K63-polyUb chain assembly
during recovery from DNA damage. We first investigated
whether inhibition of K63-polyubiquitination would sensitize
cells to agents known to sensitize yeast mutants in the error-
free damage-avoidance arm of DDT [2,3]. We found that
cisplatin, a chemotherapeutic agent highly toxic to yeast
mutants in this pathway [2,3], is also significantly more toxic
to A549 cells expressing K63R-Ub (Figure 2). This sensitivity is
Figure 1. Disruption of K63-PolyUb Chain Assembly
(A) Cartoon depicting dominant negative K63R-Ub-GFP construct. The expressed fusion protein is processed by endogenous Ub proteases generating
free GFP used for detection on a flow cytometer and mono-K63R-Ub. Incorporation of this mutant will terminate K63-polyUb chains while not affecting
canonical K48-polyUb chain assembly.
(B) Whole-cell lysates were isolated from untransfected cells, and from cells stably expressing either WT-Ub or K63R-Ub, followed by immunoblot
analysis with antibodies directed against Ub, His, and GFP.
(C) The growth of untransfected, WT-Ub, or K63R-Ub cells was followed by cell counting over the course of 7 d.
DOI: 10.1371/journal.pgen.0020116.g001
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specific to expression of K63R-Ub since the response of cells
expressing either WT-Ub or K33R-Ub is identical to that of
untransfected controls (Figure 2A and 2B). This effect was not
mediated by a general inhibition of ubiquitination since A549
cells expressing the K48R-Ub mutant are not sensitized
(unpublished data). Furthermore, a K63R-Ub clone that lost
expression of the transgene (as evidenced by a low GFP signal)
returned to normal sensitivity (Figure 2B). These data imply
Figure 2. Cells Deficient in K63-Ub Chain Formation Are Sensitized to Cisplatin Treatment while UV Sensitivity Is Revealed only upon POLg Knockdown
(A and B) Clonogenic survival assays were used to determine sensitivity to 1 h acute treatment with cisplatin in untransfected A549 cells or in A549 cells
stably expressing WT-Ub or K63R-Ub. The mean values of three independent experiments are shown with standard error of the mean (error bars). Cells
expressing K33R-Ub or cells that lost K63R-Ub expression revert to WT-Ub cisplatin sensitivity.
(C) Cells were treated for 24 h with 100 lM cisplatin followed by Hoechst staining to detect apoptosis. The mean values of three independent
experiments are shown with standard deviation.
(D) Clonogenic survival assays were used to determine sensitivity to UV irradiation in untransfected A549 cells or in A549 cells stably expressing WT-Ub
or K63R-Ub.
(E) Clonogenic survival of A549 cells stably expressing WT-Ub or K63R-Ub with or without POLg RNAi following 10 J/m2 UV treatment.
DOI: 10.1371/journal.pgen.0020116.g002
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that K63-polyUb chain assembly is essential for recovery from
at least a subset of cisplatin-induced lesions.
We also examined the functional importance of K63-
polyubiquitination in the recovery from UV-induced damage.
In contrast to the data with cisplatin, the cell line with stable
expression of K63R-Ub exhibited a dose response to UV
irradiation that was identical to the parental cells or to cells
expressing WT-Ub (Figure 2D). Thus, despite evidence that
K63-polyUb chains are required for cisplatin tolerance, we
found no evidence that disruption of K63-polyUb chain
assembly on its own influences UV toxicity. A possible
explanation for this lack of sensitivity to UV irradiation is
that cells can compensate for loss of K63-polyUb–dependent
repair through increased utilization of the error-prone TLS
arm of the pathway. A similar situation occurs in yeast where
inhibition of the error-free damage-avoidance arm of DDT
results in a much milder UV sensitivity than mutations in
RAD6 or RAD18 which additionally prevent TLS [33]. Using
siRNA, we were able to knock down expression of POLg by
;13-fold (Figure S1). Similar to inhibition of K63-polyubi-
quitination, knockdown of POLg had no effect on UV
sensitivity on its own. This observation is not unexpected
since XPV cells (defective in POLg) are not sensitive to killing
by UV irradiation. In contrast, knockdown of POLg in cells
also expressing K63R-Ub did cause increased cell kill after UV
treatment (Figure 2E). This increase in UV sensitivity suggests
that K63-polyUb and POLg function in distinct, comple-
mentary pathways that mediate recovery from UV-induced
damage.
Disruption of K63-PolyUb Chain Assembly Increases UV-
Induced Mutations
Disruption of the error-free arm in yeast is also known to
result in a dramatic increase in UV-induced mutations that is
synergistic with the TLS mutant, REV3 [34]. If playing a
similar role in mammalian cells, inhibition of K63-polyubi-
quitination should also increase UV-induced mutations. We
thus analyzed mutation induction at the HPRT locus after UV
irradiation and cisplatin exposure in these same cell lines as
well as in normal human fibroblasts expressing WT-Ub or
K63R-Ub (Figure 3). Consistent with this hypothesis, A549
cells expressing K63R-Ub show a 2.5-fold increase in UV-
induced mutations compared to cells expressing WT-Ub
(Figure 3B), and a similar increase (2.2-fold) is observed in
normal fibroblasts (Figure 3C). Untransfected and WT-Ub–
expressing cells have similar mutation frequencies (unpub-
lished data). The increase in mutations upon inhibition of
K63-polyubiquitination is consistent with a recent report that
used antisense to suppress the expression of MMS2 in human
cells [25]. Similar to the cells expressing Ub-K63R, loss of
MMS2 led to an ;2-fold increase in UV-induced mutations
without increasing UV-induced cell death [25]. Thus, both the
enzyme that is implicated in the synthesis of K63-polyUb
chains, and the chains themselves, are required for recovery
from UV damage through a pathway that prevents mutations.
Increases in UV-Induced Mutations Are Due to Increased
Utilization of TLS
Many of the TLS polymerases are known to be important
contributors to UV-induced mutagenesis as is illustrated by a
reduction in mutation frequency when inactivated in yeast
[35–38]. The data presented thus far are consistent with a
model in which inhibition of K63-polyubiquitination in-
creases UV-induced mutations owing to increased use of the
error-prone branch of the TLS pathway. However, the
possibility that K63R-Ub expression in some way increases
mutations by affecting the function of one or more TLS
polymerases cannot be ruled out. In fact, the phenotype of
cells expressing K63R-Ub is similar to that described for XPV
cells. Both cell types display an increase in UV-induced
mutations with no significant change in UV-induced cell
death. In XPV cells, this is due to loss of POLg which
replicates past T–T dimers in an error-free manner [39].
Defects in POLg can be revealed by a significant increase in
UV sensitivity when irradiated in the presence of caffeine, an
assay used to establish the XPV phenotype [40]. However, we
found that cells expressing K63R-Ub are not similarly hyper-
sensitive to this combined treatment (Figure 3E), suggesting
no overt defect in POLg function in these cells.
In contrast, our data suggest that POLg and K63-polyUb
chains participate in separate, alternative pathways for
recovery from UV-induced DNA damage. Consistent with
this idea, knockdown of POLg in combination with the
inhibition of K63-polyUb chain assembly resulted in both an
increased toxicity to UV irradiation (Figure 2E) and in a
further increase in UV-induced mutations (Figure 3D).
Interestingly, the number of mutations in cells following
knockdown of POLg in combination with inhibition of K63-
polyUb chain assembly were far greater than additive. As
expected, loss of POLg, which replicates past T–T dimers
with high fidelity, resulted in a large induction in UV-induced
mutations in WT-Ub–expressing cells (Figure 3D). These
mutations are likely due to the activity of alternative TLS
polymerases that can substitute for POLg, but which are
error-prone across T–T dimers [41]. Additional suppression
of K63-polyUb chain assembly increased the number of UV-
induced mutations by 3.5-fold. This synergistic increase in
mutations strongly suggests that the inability to form K63-
polyUb chains places a greater requirement on the TLS
pathway, and thus POLg; it is also likely that there will be a
greater requirement for other lesion bypass polymerases such
as POLf [42,43] for recovery from UV damage. Moreover, the
synergistic increase in mutations suggests that a significant
proportion of the repair is normally carried out by the error-
free component of the damage-avoidance pathway.
To further investigate the relationship between inhibition
of K63R-polyUb chain assembly and TLS, we examined the
spatial dynamics of the TLS polymerase POLg. This polymer-
ase is recruited to sites of damage and can be visualized in
discrete foci that co-localize with PCNA [44]. We analyzed the
effects of K63R-Ub expression on POLg foci formation in live
cells using a POLg-GFP fusion construct [44] (Figure 4). Since
our original cells co-expressed GFP, we generated new stable
lines from both A549 and HeLa cells expressing WT-Ub or
K63R-Ub fused with the puromycin-resistance gene. These
cell lines are phenotypically equivalent to the original GFP-
expressing cells (an ;3-fold increase in HPRT mutants in
cells expressing K63R-Ub compared to WT-Ub). Similar to
previous observations [44], the majority of nonirradiated cells
show homogenous nuclear distribution of the tagged poly-
merases (Figures 4 and S2). Foci were observed in ;11%–
12% of cells and likely represent sites of ongoing replication
[44]. When treated with 10 J/m2 UV irradiation, the
percentage of cells with foci increased to 30% in cells
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expressingWT-Ub and to 49% in cells expressing K63R-Ub 6 h
posttreatment (Figure 4B and 4D). This corresponds to an
;2-fold increase in UV-induced foci as a consequence of
inhibition of K63-polyubiquitination (2.4-fold increase over
background for WT-Ub versus 4.6-fold for K63R-Ub, p ,
0.007).
We also analyzed the co-localization of these foci with sites
of DNA replication as revealed by positive PCNA foci. We
found that in both WT-Ub and K63R-Ub–expressing cells,
100% of the UV-induced POLg foci co-localized with PCNA
foci (Figure 4A). This suggests that the foci produced in the
K63R-Ub–expressing cells are typical of those previously
reported to occur at sites of blocked replication [44]. To rule
out the possibility that UV differentially affects the cell cycle
in the two cell lines (and thus the number of cells in the S
phase), we measured cell-cycle distributions before and after
UV treatment and found no significant differences (Figure
S3). In both cell lines, the percentage of cells with foci after
UV treatment increased rapidly during the first 30 min and
then reached a plateau after 3–4 h (Figure 4B). Thus, although
Figure 3. Cells Deficient in K63-Ub Chain Formation Are Mutagenic in Response to UV Treatment
(A and B) Cells were treated with cisplatin for 1 h or UV irradiation and subcultured for 7 d. Cells were then plated and grown in 6-TG to select for HPRT
mutants. The mean values of three independent experiments are shown with standard deviation.
(C) Normal fibroblasts stably expressing WT-Ub or K63R-Ub were UV-irradiated (10 J/m2) and cultured for 5 d. Cells were then plated and grown in 6-TG
to select for HPRT mutants.
(D) The number of HPRT mutants was quantitated for A549 cells stably expressing WT-Ub or K63R-Ub with or without POLg RNAi. Cells were treated as
described in Figure 3C.
(E) Cells were UV-irradiated and plated in the absence or presence of 0.4 mM caffeine. The mean values of three independent experiments are shown
with standard error of the mean (error bars).
DOI: 10.1371/journal.pgen.0020116.g003
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the percentage of positive cells was consistently higher in cells
expressing K63R-Ub, the kinetics of foci formation are
similar. This supports the argument that the K63R-Ub mutant
is not interfering in some way with TLS polymerase recruit-
ment dynamics. Interestingly, the magnitude of the increase
in foci formation in the K63R-Ubmutant cells is similar to the
increase in UV-induced mutation frequency in these cells
(Figures 3B and 4B).
We also looked for possible changes in the types of
mutations induced by UV irradiation after inhibition of
K63-polyubiquitination. The two predominant UV-induced
lesions are the cis-syn cyclobutane pyrimidine dimer (CPD)
Figure 4. Disrupting K63-PolyUb Chain Formation Increases Reliance of Cells on the Error-Prone TLS Pathway
(A) HeLa cells stably expressing WT-Ub-puro or K63R-Ub-puro were transiently transfected with a plasmid expressing a POLg-GFP fusion. Twenty-four
hours post-transfection, cells were UV-irradiated (10 J/m2). POLg (green) and PCNA (red) were detected using antibodies. Shown are representative
confocal photographs of cells 6 h post-UV treatment.
(B) Kinetics of POLg foci formation in WT-Ub– and K63R-Ub–expressing HeLa cell lines.
(C) HPRT mutation spectra. RNA was isolated from 6-TG resistant 10 J/m2 UV-treated clones followed by RT-PCR and sequence analysis of the HPRT
locus. The UV-induced mutations are shown in the upper table. Most of the point mutations were G!A or C!T transitions indicated as G/C!A/T. The
lower table in (C) shows the same mutants in sequence context.
(D) Foci were quantitated 6 h post-UV treatment using a live-cell imaging fluorescent microscope.
(E) The number of HPRT mutants was quantitated for A549 cells stably expressing K63R-Ub with or without RAD18 RNAi. Cells were treated as described
in Figure 4B.
DOI: 10.1371/journal.pgen.0020116.g004
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and the pyrimidine-6/4-pyrimidone (6–4PP) photoproduct
[45,46]. The most common lesion is the thymine–thymine
CPD (represented by T–T) followed by T–C and the thymine–
cytosine 6–4PP (represented by T(6,4)C) [47]. Levels of
T(6,4)T, C–T, and C–C lesions are comparatively much lower.
However, the normal spectrum of UV-induced mutations
does not match this pattern of damage induction. Mutations
are primarily C to T transitions that arise at T–C and C–C
sites due to mis-incorporation of adenine opposite the 39C
[48,49]. The weak contribution of the T–T lesion to mutation
may be explained by the activities of POLg and POLi, which
accurately bypass T–T and T(6,4)T lesions, respectively
[50,51].
To further probe for possible changes in the function of
these polymerases upon inhibition of K63-polyubiquitina-
tion, we examined the spectrum of UV-induced mutations in
cells expressing K63R-Ub. By sequence analysis of the
expressed HPRT transcript, we found that the increase in
mutations noted in Figure 3 can be accounted for entirely by
additional point mutations. We sequenced 20 of these
mutations and found that they were all located at dipyr-
imidine sites (Table 1). The majority of mutations were C to T
transitions (80%), with most of these being TC to TT (55%)
(Figure 4C). These data are consistent with the mutation
spectrum of other normal cell lines and contrast with data
reported for cells with disruptions in TLS polymerases [48–
50,52]. Importantly, inhibition of K63-polyubiquitination did
not cause any mutations at T–T sites, suggesting normal
function of both POLg and POLi in these cells.
Collectively, these data suggest that inhibition of K63-
polyUb chain assembly results in an increased requirement
for TLS after UV irradiation and consequently increased
numbers of visible TLS foci, and an increase in TLS-
associated mutations. To further support this assertion, we
examined the dependence of the observed phenotype on
RAD18 function. We transfected our WT-Ub and K63R-Ub–
expressing stable cell lines with siRNA directed against
RAD18 using conditions which consistently showed .10-fold
reduction in expression (Figure S1). In both cell lines, UV-
induced POLg foci formation was abrogated by RAD18
knockdown, implying that the recruitment of TLS poly-
merases to sites of damage are RAD18-dependent (Figure 4D).
This is similar to previous reports showing the requirement
of RAD18 for POLg foci formation [11]. Significantly, the
UV-induced foci formation in K63R-Ub–expressing cells was
also reduced to nonirradiated levels, suggesting that the
increased number of foci that are found in cells expressing
the K63R mutant is also downstream of RAD18. RAD18 has
been previously shown to be important for recombinational
repair, and RAD18-knockout mouse embryonic stem cells
exhibit more sister chromatid exchanges in response to DNA
damage [53]. The combination of disrupting K63R-polyUb
chain formation and RAD18 knockdown did not show an
increase in mutations; in fact a modest, but non-significant,
decrease was observed (Figure 4E). The lack of an additive
Table 1. Disrupting K63-PolyUb Chain Assembly Induces a Characteristic UV Mutation Signature
Mutation Type Pyrimidine Dimer Sequence Change Position (Strand) Exon Amino Acid Mutant
TC ! TT TATT(C.T)ATTA 674 (ÿ) 8 Glu ! Lys U26–2 27
TC ! TT TATT(C.T)ATTA 674 (ÿ) 8 Glu ! Lys U26–2 26
TC ! TT TATT(C.T)ATTA 674 (ÿ) 8 Glu ! Lys U26–2 10
TC ! TT ACGT(C.T)TTGC 230 (þ) 3 Leu ! Phe U5G1
TC ! TT TAAT(C.T)CAAA 548 (þ) 6 Pro ! Ser U26–2 28
TC ! TT GGTT(C.T)ATCA 125 (ÿ) 2 Glu ! Lys U8B3
G/C ! A/T TC ! TT ATGT(C.T)TTGA 475 (þ) 5 Val ! Val U26–2 17
or TC ! TT TAAT(C.T)CAAA 548 (þ) 6 Pro ! Ser U26–2 17
C/G ! T/A TC ! TT TTGT(C.T)TGGA 638 (ÿ) 8 Asp ! Asn U26–2 20
TC ! TT TATT(C.T)ATTA 674 (ÿ) 8 Glu ! Lys U26–2 20
TC ! TT TGCT(C.T)GAGA 236 (þ) 3 Arg ! STOP U26–2 1
CT ! TT ATTC(C.T)TATG 366 (þ) 3 Pro ! Leu U4E2
CT ! TT CTTG(C.T)TCGA 234 (þ) 3 Ala ! Val U26–2 1.1
CT ! TT CTTG(C.T)TCGA 234 (þ) 3 Ala ! Val U26–2 18.1
CT ! TT CTTG(C.T)TCGA 234 (þ) 3 Ala ! Val U26–2 36.1
CT ! TT CTTG(C.T)TCGA 234 (þ) 3 Ala ! Val U26–2 5.1
G/C ! T/A TC ! TA TTGT(C.A)TGGA 638 (ÿ) 8 Asp ! Tyr U26–2 33
or TC ! TA TATT(C.A)ATTA 674 (ÿ) 8 Glu ! STOP U1G11
C/G ! A/T
G/C ! C/G
or CC ! CG CCAC(C.G)AATT 437 (ÿ) 4 Gly ! Arg U6E6
C/G ! G/C
A/T ! T/A
or TC ! AC CAAA(T.A)CCAA 625 (ÿ) 8 Gly ! Gly U26–2 35
T/A ! A/T
A549 cells stably expressing K63R-Ub were treated with 10 J/m2 UV, further cultured for 7 d and then seeded in media containing 6-TG. Single colonies were picked from each dish to
ensure that no sister clones would be analyzed. The HPRT gene was then amplified by RT-PCR followed by sequencing using four overlapping primers. The mutants are grouped by
observed point mutations and inferred pyrimidine dimers.
DOI: 10.1371/journal.pgen.0020116.t001
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mutation effect supports the foci data implicating a role for
K63-polyUb chain formation downstream of RAD18.
PCNA Is Polyubiquitinated
Our data support a role for the formation of K63-polyUb
chains in promoting the recovery of human cells from DNA
damage through an error-free pathway that is distinct from
TLS. A likely target of this polyubiquitination is PCNA, which
in yeast is modified by K63-polyUb via the RAD5/MMS2
complex. However, similar modification of PCNA has not
been observed in UV-irradiated human cells [29]. We
investigated PCNA modification after UV irradiation in three
separate human cell lines: A549 lung cancer cells; 293T
embryonic kidney cells; and Hela cervical cancer cells. Six
hours following a dose of 30 J/m2, we observed the
appearance of a prominent band consistent with mono-
ubiquitinated PCNA, and overexposure of this blot revealed
additional PCNA-immunoreactive bands of higher molecular
weight consistent with PCNA modified with 2, 3, and 4 Ub
molecules (Figure 5).
As it has been previously demonstrated that RAD18 is
required for the mono-ubiquitination of PCNA in human
cells, and that this monoUb PCNA species is required as a
substrate for UBC13-mediated K63-polyubiquitination in
yeast, we sought to determine whether the observed higher
molecular weight bands are dependent on either RAD18 or
UBC13. To this end, the expression of RAD18 or UBC13 was
knocked down using the appropriate siRNAs (Figure S1). As
expected, the band corresponding with monoUb PCNA was
substantially reduced in lysates from RAD18 siRNA-trans-
fected cells, and this also resulted in suppression of the higher
molecular weight (polyUb) forms of PCNA presumably
modified with 2, 3, or 4 Ub molecules (Figures 5B and S4A).
In contrast, knockdown of the E2 Ub ligase responsible for
K63-polyubiquitination had no effect on the formation of
monoUb PCNA after UV irradiation, but did effectively
reduce the di, tri, and quad polyUb PCNA bands to levels
similar to those in the RAD18 knockdowns (Figures 5B and
S4A). Together these data suggest that in both cell lines
tested, UV induces modification of PCNA by both monoUb
(in a RAD18-dependent manner) and by K63-polyUb chains
of length 2, 3, and 4 (in a RAD18 and UBC13-dependent
manner).
To further demonstrate that these higher molecular weight
species are indeed ubiquitinated forms of PCNA, we
immunoprecipitated PCNA from A549, 293T, and Hela cells,
and probed using an antibody directed against Ub or PCNA
(Figure 5C). In addition, we excluded the possibility that an
ubiquitinated protein was co-immunoprecipitated with
PCNA by lysing cells in boiling 0.5% sodium dodecyl sulfate
(SDS) to ensure dissociation of PCNA complexes. Following a
5-fold dilution (0.1% SDS), the lysates were immunoprecipi-
tated. Under these conditions, we reproducibly observed
several higher molecular weight bands consistent with
polyubiquitination of PCNA in each of the three cell lines
(Figure 5C and 5D, and Figure S4B and S4C). These Ub-
immunoreactive bands correspond well with the predicted
molecular weights for di-, tri-, and quad-ubiquitinated PCNA.
The antibody against Ub reproducibly demonstrated less
affinity for the mono-ubiquitinated form of PCNA, although
this was clearly the most abundant form as shown by PCNA
immunoblots (Figure 5C and 5D, and Figure S4B and S4C).
This appears to be a characteristic of the antibody, as we have
seen this reproducibly for other ubiquitinated proteins
(unpublished data).
Interestingly, each of the cell lines, particularly 293T cells,
also show low levels of PCNA polyubiquitination in the
absence of UV irradiation. However, in all cases the Ub-
immunoreactive bands are significantly increased upon
irradiation in a manner consistent with the increase in
mono-ubiquitinated PCNA (Figure 5C and 5D, and Figure
S4B and S4C). Similar to previous reports [29], mono-
ubiquitinated PCNA was readily visible 1.5 h after UV
treatment and remained present for up to 24 h as detected
by the PCNA antibody (Figure S4B). Similarly, bands
consistent with di, tri, and quad polyUb forms of PCNA
became visible within 1.5 h following UV irradiation, and
remained present up to 24 h after exposure (Figure S4B).
Importantly, consistent with the PCNAWestern blots (Figures
5B and S4A), the Ub-immunoreactive bands following PCNA
IP in both Hela (Figure S4C) and 293T (Figure 5D) cells were
substantially reduced following knockdown of either RAD18
or UBC13. As expected, RAD18 knockdown blocked both
mono-ubiquitination and polyubiquitination of PCNA,
whereas UBC13 knockdown inhibited only the di, tri, and
quad polyUb forms (Figure 5B and 5D, and Figure S4A and
S4C).
Collectively, these data show that PCNA is indeed modified
by polyUb chains in human cell lines. Similar modification
was observed in primary skin and lung fibroblasts (unpub-
lished data) and in response to other forms of damage such as
cisplatin (Figure S5). We speculate that the lack of PCNA
polyubiquitination reported earlier [29] may be explained by
technical difficulties in detecting Ub owing to its strong
tertiary structure [54], the low abundance of polyubiquiti-
nated PCNA, or perhaps differences in cell types. In our
studies, Ub blots were autoclaved to overcome detection
problems associated with its strong tertiary structure [54]. We
also excluded the possibility that DUB enzymes in cell lysates
may have activity against ubiquitinated PCNA by repeating
the immunoprecipitation in the presence of N-ethylmalei-
mide (NEM), a nonspecific inhibitor of DUBs (Figure S6).
Under these conditions, no change in PCNA polyubiquitina-
tion was observed.
Discussion
The highly conserved Ub protein serves as a pleiotropic
covalent tag for many cellular proteins. It has essential
proteolytic and nonproteolytic functions that are based on
the length and topology of the chain formed. The pathway in
which Ub is most commonly associated is the proteasome
pathway, a system for targeting protein substrates via K48-
linked polyUb chains for degradation in the 26S proteasome
[55]. However, there is increasing evidence that Ub plays an
important role in a number of nonproteolytic pathways
including receptor internalization [56], translation [57], signal
transduction [28], gene regulation [58], and DNA repair
[5,6,14,25,29,59]. These roles appear to be mediated in part by
the non-canonical polyUb chains. Much less is known about
this aspect of ubiquitination compared with the role of K48-
polyUb in protein degradation. Of particular interest are
chains linked through K63, as genetic studies in S. cerevisiae
have shown that the enzymatic complex (RAD5, UBC13/
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MMS2) that assembles these chains is required to protect cells
from the harmful effects of genotoxic agents by allowing the
replication machinery to bypass DNA lesions in a faithful
manner [14]. In fact, ubiquitination of the DNA polymerase
processivity factor PCNA is emerging as a key ‘‘molecular
switch’’ for DDT [5,6,29]. Mono-ubiquitination of PCNA
promotes error-prone TLS, while K63-polyUb activates
error-free damage avoidance. The body of evidence support-
ing the requirement of PCNA post-translational modifica-
tions for DDT in mammalian cells is only now emerging.
In this report, we provide evidence to support a model
(Figure 6) in which ubiquitination of PCNA acts at a central
decision point to direct the recovery of blocked replication
forks towards one of two alternative pathways in mammalian
cells. Recent reports have confirmed that RAD6-dependent
mono-ubiquitination of PCNA also stimulates TLS in human
Figure 5. Modification of PCNA by Polyubiquitin in Human Cells after DNA Damage
(A) A549, 293T, and Hela cells were irradiated with 0 or 30 J/m2 UV and lysed 6 h posttreatment followed by immunoblotting for PCNA.
(B) 293T cells were transfected with 100 nM of either control siRNA, siRNA Ubc13, or siRNA RAD18. Seventy-two hours post-transfection, cells were
treated as described in Figure 1A. A darker and lighter exposure of the PCNA immunoblot is shown.
(C) A549, 293T, and Hela cells were irradiated with 30 J/m2 UV and lysed in boiling SDS, diluted in lysis buffer and subjected to immunoprecipitation
with a PCNA antibody and detected with PCNA or Ub antibodies. The controls in the immunoprecipitations were ‘‘no 1’’, in which lysates were
incubated with beads but no PCNA antibody, and ‘‘1 B’’ in which PCNA antibody was incubated with beads alone.
(D) 293T cells were transfected as described in Figure 5B. Seventy-two hours post-transfection, cells were irradiated with 30 J/m2 of UV and lysed 6 h
later in boiling SDS, diluted in lysis buffer, and subjected to immunoprecipitation with a PCNA antibody and immunoblotted for PCNA (upper panel)
and Ub (lower panel). A lighter exposure of the PCNA IP immunoblotted for Ub is also shown. A PCNA immunoblot with darker and lighter exposure
performed on protein lysates from the same samples used in the immunoprecipitations is also shown. Asterisks denote immunoglobulin heavy and
light chains as detected on the immunoprecipitations.
DOI: 10.1371/journal.pgen.0020116.g005
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cells. This stimulation appears to result through direct
binding of the TLS polymerases to mono-ubiquitinated
PCNA [11,29].
Our data indicate that formation of K63-polyUb chains is
required to utilize an error-free pathway distinct from TLS.
This pathway is required for cell survival from at least some
types of DNA damage, as its inhibition cannot be compen-
sated for by the alternative TLS pathway in the case of
cisplatin-damaged cells. For UV-induced damage, inhibition
of K63-polyubiquitination does not affect overall cell survival,
but instead causes an increase in mutations arising from an
apparent increased requirement for the error-prone branch
of TLS. This is supported by several lines of evidence. First,
blockade of K63-polyUb chain formation led to a 2.4-fold
increase in RAD18-dependent TLS foci after UV irradiation.
Second, we found that the number of UV-induced mutations
increased by a similar factor in these cells, and that the
spectra of these mutations are consistent with that produced
normally by error-prone TLS polymerases after UV treat-
ment. Third, POLg knockdown in combination with blockade
of K63-polyUb chain formation led to increased toxicity to
UV irradiation, although no change was seen with either
individually. Fourth, an increased reliance on the TLS arm
upon blockade of K63-polyUb chain assembly was revealed by
a synergistic increase in UV-induced mutations when ex-
pressed in POLg knockdown cells. POLg knockdown cells
showed a high mutation rate as expected, but this rate
increased by a factor of 3.5 when K63-polyUb chain assembly
was inhibited.
Together, these data imply that formation of K63-polyUb
chains can activate an error-free mechanism to protect cells
against mutations that would otherwise be induced by the
error-prone TLS polymerases. It will be of interest to
determine whether K63-polyUb chain formation also plays
a role in protection against sunlight-induced skin cancer.
An obvious question that emerges is how formation of K63-
polyUb acts to suppress TLS. Recent reports have demon-
strated that the TLS polymerases POLg and POLi both bind
directly and avidly to polyUb chains through newly discov-
ered binding domains [20,60]. A C-terminal zinc finger
domain of POLg and the proline residue at position 692 of
POLi are required for the respective interaction with Ub [20].
Together with our data, this suggests a possible mechanism
whereby differential ubiquitination of PCNA could act as a
switch between TLS and an alternative error-free pathway
(Figure 6). In this model, the TLS polymerases are recruited
to the sites of replication through interaction with mono-
ubiquitinated PCNA and subsequently mediate TLS across
DNA lesions. Extension of the Ub chain through K63-linked
polyubiquitination in some way suppresses TLS activity and
promotes recovery through an alternative error-free path-
way. This suppression may be mediated through the recently
discovered ability of POLg and POLi to directly bind K63-
polyUb chains. An intriguing possibility is that K63-polyUb
chains are cleaved upon binding to TLS polymerases, thereby
functionally removing them from the site of the lesion. This
possibility is supported by the low detectable levels of
polyubiquitinated PCNA as well as by the observed increase
in POLg foci in K63R-Ub–expressing cells.
Although our data suggest that PCNA is indeed a target for
K63-polyubiquitination, they do not exclude the possibility
that other key proteins in this pathway are also important
substrates for these chains. Indeed, K63-polyubiquitination
occurs on at least three proteins (RIP, NEMO, and TRAF6) in
an unrelated pathway that activates NF-jB [28,61,62]. In this
pathway, K63-polyUb chains on multiple proteins may
facilitate their assembly into an active complex [62]. It is
therefore intriguing to speculate that K63-polyUb chains may
not only uncouple the TLS polymerases from the site of
damage, but may also provide a mechanism for recruitment
of other proteins required for error-free repair.
Non-proteolytic roles for Ub have also been implicated in
other DNA-repair pathways that may interact with DDT, most
notably that involving Fanconi’s anemia (FA) gene products
[18]. FANCD2 becomes mono-ubiquitinated after DNA
damage and localizes to nuclear foci [63]. FANCC has been
associated with the TLS polymerases REV1 and REV3 [64] and
Figure 6. Model of the DDT Pathway in Mammalian Cells
Recovery from a stalled replication fork at sites of DNA damage can
occur by one of two alternative pathways. Previous work has shown that
PCNA mono-ubiquitination by the RAD6/RAD18 complex stimulates
lesion bypass through recruitment of the error-prone TLS polymerases.
Here we show that an alternative error-free pathway requires formation
of K63-polyUb chains. Blockade of this error-free pathway results in
increased use of the TLS polymerases after DNA damage and a
corresponding increase in mutations. As the TLS polymerases POLg
and POLi both bind directly and avidly to polyUb chains [20], it is
hypothesized that the interaction with K63-polyUb causes a disengage-
ment of the polymerase from the DNA, allowing other proteins to
migrate to the site of damage to perform error-free repair. This model
predicts that K63-polyubiquitination acts to suppress environmental
carcinogenesis by preventing genomic instability that would otherwise
be introduced by the TLS polymerases.
DOI: 10.1371/journal.pgen.0020116.g006
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may also interact with the BLM helicase [65], a candidate for
promoting fork reversal in the error-free damage-avoidance
pathway [66]. A challenge for future investigations will be to
understand how K63-polyUb chain assembly is regulated and
how these chains promote interaction with other pathways to
mediate error-free recovery from DNA damage.
Materials and Methods
Cell culture and treatments. The construction of the Ub-expressing
plasmids has been described elsewhere [31]. The POLg-GFP plasmid
was a gift of Dr. Alan R. Lehmann, (Genome Damage and Stability
Centre, University of Sussex, Falmer, Brighton, United Kingdom). All
cell lines were cultured in DMEM (Sigma, St. Louis, Missouri, United
States) supplemented with 10% FBS (Sigma). A549 cells were co-
transfected with WT-Ub-GFP or K63R-Ub-GFP plasmids and the
pBabePuro plasmid (for selection) using FuGene 6 (Roche, Basel,
Switzerland). HeLa cells were transfected with WT-Ub-puro or K63R-
Ub-puro constructs using lipofectamine (Invitrogen, Carlsbad, Cal-
ifornia, United States). Stable transfectants were selected in 1 lg/ml
puromycin (Sigma) and/or by flow cytometry (FACSAria, BD
Biosciences Pharmingen, San Diego, California, United States).
The sensitivity to UV irradiation alone, UV combined with
caffeine, and cisplatin alone was evaluated using clonogenic survival
assays. UV irradiation was performed on 80% confluent cells in 6-cm
dishes using a UVC (254-nm) germicidal lamp at a dose rate of 1 J/m2/
s. UV and caffeine combination studies were carried out as above, but
cells were plated in 0.4 mM caffeine immediately after UV
irradiation. Cells were treated for 1 h in cisplatin diluted in culture
media. Cells were plated in 6-cm dishes in triplicate and incubated
for 2 wk to obtain colony formation. Colonies were fixed, stained with
2% bromophenol blue in 70% ethanol, and colonies containing 50
cells were counted. All experiments were normalized for plating
efficiency.
The sensitivity to UV irradiation in POLg knockdown cells was
performed as above with the exception that cells were transfected
twice with SiGenome Smartpool reagent specific for human POLg
(Dharmacon Research, Lafayette, Colorada, United States) using
oligofectamine (Invitrogen). The transfections were carried out 72
and 24 h before UV treatment to achieve optimal long-term
knockdown as determined by quantitative RT-PCR.
Quantitation of gene expression was performed using an Applied
Biosystems (Foster City, California, United States) 7500 Real-Time
PCR system using their ‘‘assay on demand’’ technology. RAD18
expression was determined with the Hs00220119_m1 probe, POLg
with the Hs00197814 probe, and 18S with the Hs99999901_s1 probe.
Reactions were performed using Taqman Universal PCR Master Mix
from Applied Biosystems.
Immunoblotting. Following the indicated treatments with either
UV irradiation, cisplatin, and/or SiGenome Smartpool reagent
specific for human UBC13 or human RAD18 (Dharmacon), cells
were harvested in lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 1% Triton-X-100, 2 mM EDTA, and 5% glycerol with 200 lg/ml
phenylmethylsulfonyl fluoride, 2 mM NaVO4, 2 mM NaF, and 2 mM
NaPPi protease-inhibitor cocktail). Samples were sonicated, soluble
fractions were recovered, and proteins were quantified using the
Bradford protein assay (Bio-Rad). Proteins were resolved on either a
single-phase (10%) or two-phase SDS-polyacrylamide gel (10% and
15%) and electroblotted onto a Hybond C nitrocellulose membrane
(Amersham Pharmacia Biotech, Piscataway, New Jersey, United
States). The membrane was stained with Ponceau S (Sigma) prior to
Western blotting with the indicated primary antibody. The following
antibodies were used: rabbit polyclonal Ub (Dako, Glostrup, Den-
mark), mouse monoclonal RGS-His (Qiagen, Valencia, California,
United States), mouse monoclonal PCNA PC10 (Chemicon, http://
www.chemicon.com), rabbit polyclonal GFP (Santa Cruz Biotechnol-
ogy, Santa Cruz, California, United States), and mouse monoclonal
actin (Sigma). Proteins were visualized by a horseradish peroxidase
method using ECL (Kirkegaard and Perry Laboratories, http://www.
kpl.com).
Immunoprecipitation. Cells were UV-irradiated with 30 J/m2 as
described above and either left untreated or transfected with
SiGenome Smartpool reagent specific for human UBC13 or human
RAD18 (Dharmacon). Cells were lysed (6 h after irradiation) in lysis
buffer supplementedwith 0.5%SDS.Lysateswere sonicated andboiled
for 5min followed by dilution to 0.1%SDS. After protein quantitation,
500 lg of protein was incubated overnight at 4 8C with anti-PCNA (1/
200). The following day, lysates were incubated for 48 h at 4 8Cwith 100
ll of Gamma-Bound Sepharose Beads (AmershamPharmacia Biotech).
Beads were washed extensively in lysis buffer, and proteins were eluted
by boiling in Laemmli’s SDS sample buffer. Immunoblotting was
performed as described above except that the membranes were
autoclaved for 20 min in ddH2O after protein transfer, and proteins
were visualized using SuperSignal West Pico Chemiluminescent
Substrate (Pierce Biotechnology, Rockford, Illinois, United States).
Mutation spectrum. To eliminate background HPRT mutations,
cells were cultured in hypoxanthine, aminopterin, and thymidine
(HAT)–supplemented culture medium for 1 wk. UV-induced HPRT
mutants were obtained by seeding 1.5 3 104 cells in 24-well plates,
followed by 10 J/m2 UV irradiation 24 h later. Cells were subcultured
for 7 d, and re-seeded at 5.03 104 cells on 35-mm dishes in medium
containing 30 lM 6-thioguanine (6-TG). Individual colonies were
picked and grown until enough cells were obtained for RNA isolation
using RNA-aqueous kit (Ambion, Austin, Texas, United States). The
HPRT gene was subjected to RT-PCR, followed by sequencing using
the following overlapping primers: HPRT1–59CTTCCTCC-
TCCTGAGCAGTC39; HPRT2–59AAGCAGATGGCCACAGAACT39;
HPRT3–59CCTGGCGTCGTGATTAGTG39; HPRT4–59TTTACTGGC-
GATGTCAATAGGA39; HPRT5–59GACCAGTCAACAGGGGACAT39;
and HPRT6 59ATGTCCCCTGTTGACTGGTC39.
Mutation frequency. HPRT mutant–free cells (1.0 3 106) were
seeded and treated the following day with either UV irradiation (0, 5,
and 10 J/m2) or cisplatin (0, 5, and 10 lM for 1 h). After subculturing
the treated cells for 1 wk, 4.0 3 105 cells were seeded in selective
medium containing 6-TG (as above) and incubated until colonies
were formed. Colonies were counted and HPRT mutation frequency
was defined after correcting for plating efficiency.
Mutation frequency in response to UV treatment in POLg and
RAD18 knockdown cells was performed as above with the exception
that cells were transfected twice with SiGenome Smartpool reagent
specific for human POLg or human RAD18 (Dharmacon) using
oligofectamine. The transfections were performed 72 and 24 h before
UV treatment to achieve optimal long-term knockdown as deter-
mined by quantitative PCR.
Foci. A549 and Hela cells stably expressing WT-Ub-puro and K63R-
Ub-puro were transiently transfected with a POLg-GFP plasmid.
Twenty-four hours post-transfection, cells were UV-irradiated at a
dose of 10 J/m2. To observe living cells, cells were cultured in 35-mm
glass-bottomed dishes (MatTek, http://www.mattek.com) with cover-
slips. Real-time excitation measurements to monitor fluorescent
signals in transfected cells were subsequently performed using a live-
cell microscopy unit mounted on a Leica DR IRBE inverted
microscope (Wetzlar, Germany), equipped with a polychromator that
allows generation of light of the required wavelength, using a 633
objective. Both the polychromator and filterwheel were controlled via
the PC using specialized Openlab software from Improvision (http://
www.improvision.com/products/openlab). At least 100 cells were
counted for each cell line at each time point per experiment by a
blinded independent observer.
The recruitment of POLg to foci was determined in response to
UV irradiation in RAD18 knockdown cells performed as above with
the exception that cells were transfected twice with SiGenome
Smartpool reagent specific for human RAD18 using oligofectamine.
The transfections were performed 72 and 24 h before UV treatment
to achieve optimal long-term knockdown as determined by quanti-
tative PCR.
For colocalization studies, Hela cells stably expressing WT-Ub-puro
and K63R-Ub-puro were transiently transfected with a POLg-GFP
plasmid in a chamber slide (BD Biosciences Pharmingen). Twenty-
four hours post-transfection, cells were UV-irradiated at a dose of 10
J/m2. For detection of PCNA and POLg, cells were fixed in cold
methanol for 20 min at ÿ20 8C followed by 30 sec in cold acetone.
Cells were washed twice with PBS and then incubated at room
temperature with both anti-PCNA and anti-POLg. After 1 h, cells
were washed with PBS and then incubated with FITC-conjugated goat
antimouse IgG (Invitrogen) and Texas red–conjugated goat antirabbit
(Invitrogen), for 45 min. After washing in PBS, cells were dehydrated
for 1 min in 70% ethanol followed by two 1-min incubations in 100%
ethanol. Cells were then mounted with Fluorescent Mounting Media
(Dako) and visualized by confocal microscopy.
Supporting Information
Figure S1. Knockdown of UBC13, RAD18, and POLg
(A) Hela cells were transfected with siRNA against UBC13 and
analyzed by Western blot.
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(B) A549 cells were transfected twice (48 h apart) with siRNA against
RAD18 or POLg. Knockdown was analyzed 24 and 72 h post–second
transfection for mRNA expression relative to 18S rRNA using
quantitative RT-PCR.
Found at DOI: 10.1371/journal.pgen.0020116.sg001 (28 KB PDF).
Figure S2. Increase in POLg Foci Is Also Observed in A549 Cells
A549 cells stably expressing WT-Ub or K63R-Ub were treated as
described in Figure 4. Two independent experiments were performed.
Found at DOI: 10.1371/journal.pgen.0020116.sg002 (16 KB PDF).
Figure S3. Cell-Cycle Profile following UV Treatment
(A) A549 cells expressing WT-Ub-GFP or K63R-Ub-GFP were treated
with the indicated dose of UV irradiation.
(B) Hela cells expressing WT-Ub-puro or K63R-Ub-puro were treated
with 10 J/m2 UV irradiation and fixed either immediately or 6 h
posttreatment. Following propidium iodide staining, cells were
analyzed for DNA content using a FACSAria flow cytometer (BD
Biosciences Pharmingen).
Found at DOI: 10.1371/journal.pgen.0020116.sg003 (33 KB PDF).
Figure S4. Modification of PCNA by Polyubiquitin in Human Cells
after DNA Damage
(A) Hela cells were subjected to the same procedure as carrried out in
Figure 5B. A darker (upper panel) and lighter exposure (lower panel)
of the PCNA immunoblot is shown.
(B) A549 cells were UV-irradiated as described in Figure 5A and lysed
at the indicated times posttreatment. Whole-cell lysates were
subjected to immunoprecipitation with an anti-PCNA antibody
followed by immunoblotting for PCNA (upper panel) and Ub (lower
panel). The controls in the immunoprecipitations are the same as
carried out in Figure 5C.ÿUV indicates no UV treatment.
(C) Hela cells were subjected to the same procedure as performed in
Figure 5D. A lighter exposure of the PCNA IP immunoblotted for Ub
is shown. A PCNA immunoblot with darker and lighter exposure
performed on protein lysates from the same samples used in the
immunoprecipitations is also shown.
Found at DOI: 10.1371/journal.pgen.0020116.sg004 (67 KB PDF).
Figure S5. Cisplatin Treatment also Induces Modification of PCNA by
Polyubiquitin in Human Cells
Untreated, 30 J/m2 UV-irradiated, and 160 lM cisplatin-treated A549
and Hela cells were lysed 6 h posttreatment followed by immuno-
blotting for PCNA.
Found at DOI: 10.1371/journal.pgen.0020116.sg005 (33 KB PDF).
Figure S6. Inhibition of DUB Enzymes Does Not Affect Appearance
of PolyUb-PCNA
A549, 293T, and Hela cells were treated with 30 J/m2 UV irradiation
and lysed in the presence or absence of the general thiol protease-
inhibitor NEM. Immunoprecipitation and Western blots were carried
out as described in Materials and Methods. The controls in the
immunoprecipitations were ‘‘no 1’’, in which lysates were incubated
with beads but no PCNA antibody, and ‘‘1 B’’, in which PCNA
antibody was incubated with beads alone.
Found at DOI: 10.1371/journal.pgen.0020116.sg006 (30 KB PDF).
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